These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1709235

  • 21. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR, Settle SL, Kirk JE, Taylor SA, Moore KP, Unwin RJ.
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [Abstract] [Full Text] [Related]

  • 22. Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.
    Sybertz EJ, Chiu PJ, Vemulapalli S, Watkins R, Haslanger MF.
    Hypertension; 1990 Feb; 15(2):152-61. PubMed ID: 2154404
    [Abstract] [Full Text] [Related]

  • 23. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC, Robl JA, Asaad MM, Bird JE, Panchal BC, Schaeffer TR, Fox M, Giancarli MR, Cheung HS.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [Abstract] [Full Text] [Related]

  • 24. Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion.
    Scheuermann M, Dietz R, Willenbrock R.
    Eur J Pharmacol; 1998 Apr 24; 347(2-3):245-52. PubMed ID: 9653889
    [Abstract] [Full Text] [Related]

  • 25. Sodium loads enhance the natriuretic responses to atrial natriuretic peptide and neutral endopeptidase inhibitors in conscious cynomolgus monkeys.
    Seymour AA, Asaad MM, Abboa-Offei B, Smith PL, Rogers WL.
    Clin Exp Pharmacol Physiol; 1994 Nov 24; 21(11):845-56. PubMed ID: 7882575
    [Abstract] [Full Text] [Related]

  • 26. Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors.
    Seymour AA, Mathers PD, Abboa-Offei BE, Asaad MM, Weber H.
    J Cardiovasc Pharmacol; 1996 Sep 24; 28(3):397-401. PubMed ID: 8877586
    [Abstract] [Full Text] [Related]

  • 27. The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in normotensive and hypertensive rats.
    Nomura N, Shimamoto K, Ura N, Iwata M, Aoyama T, Takagawa Y, Iimura O.
    Clin Exp Hypertens; 1995 Nov 24; 17(8):1219-31. PubMed ID: 8563698
    [Abstract] [Full Text] [Related]

  • 28. Excretory responses to renal nerve stimulation during inhibition of neutral metalloendopeptidase and angiotensin-converting enzyme in the rat.
    Golin R, Protasoni G, Wjinmaalen P, Sala C, Monopoli A, Casati C, Zanchetti A, Stella A.
    J Cardiovasc Pharmacol; 1996 Nov 24; 28(5):665-71. PubMed ID: 8945680
    [Abstract] [Full Text] [Related]

  • 29. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T, Okahara A, Nose M, Ikuse T, Matsumura Y.
    Biol Pharm Bull; 2000 Jul 24; 23(7):820-5. PubMed ID: 10919359
    [Abstract] [Full Text] [Related]

  • 30. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
    Fitzpatrick MA, Rademaker MT, Charles CJ, Yandle TG, Espiner EA, Ikram H, Sybertz E.
    J Cardiovasc Pharmacol; 1992 Apr 24; 19(4):635-40. PubMed ID: 1380608
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats.
    Vemulapalli S, Chiu PJ, Brown A, Griscti K, Sybertz EJ.
    Life Sci; 1991 Apr 24; 49(5):383-91. PubMed ID: 1649942
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hemodynamic and humoral effects of chronic treatment with the neutral endopeptidase inhibitor SCH 42495 in spontaneously hypertensive rats.
    Sala C, Monopoli A, Casati C, Ardeleani G, Ongini E, Zanchetti A, Morganti A.
    J Cardiovasc Pharmacol; 1994 May 24; 23(5):703-8. PubMed ID: 7521451
    [Abstract] [Full Text] [Related]

  • 35. Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin.
    Lisy O, Jougasaki M, Schirger JA, Chen HH, Barclay PT, Burnett JC.
    Am J Physiol; 1998 Sep 24; 275(3):F410-4. PubMed ID: 9729514
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Atrial natriuretic peptide is involved in renal actions of moxonidine.
    Mukaddam-Daher S, Gutkowska J.
    Hypertension; 2000 Jun 24; 35(6):1215-20. PubMed ID: 10856266
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs. A possible role for kinins and luminal actions of the peptide.
    Legault L, Cernacek P, Levy M, Maher E, Farber D.
    J Clin Invest; 1992 Oct 24; 90(4):1425-35. PubMed ID: 1328299
    [Abstract] [Full Text] [Related]

  • 40. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
    Valentin JP, Qiu C, Wiedemann E, Gardner DG, Humphreys MH.
    J Pharmacol Exp Ther; 1995 May 24; 273(2):744-52. PubMed ID: 7752077
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.